15-Aug-2019 - BIH - Berliner Institut für Gesundheitsforschung

DNA saturation mutagenesis: Identifying which mutations really cause disease

Scientists at the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin, working with colleagues from the United States, have selectively modified the control regions of 20 disease-relevant genes. This enabled them to identify precisely those modifications that have the greatest influence on disease state. Their findings will now allow physicians to predict which DNA modifications found in patients are actually responsible for disease, thus highlighting them for a potential targeted therapy.

Many diseases occur because a person’s DNA contains errors, so-called mutations. These cause vital protein molecules to be produced incorrectly. Sometimes the molecules are altered to such an extent that they are no longer able to perform their function. But more often, modifications in the gene control regions (regulatory sequences, also known as promoters and enhancers) cause the wrong amount of protein to be produced. The cells produce either too much or too little protein, or none at all. “That can, for example, result in cancer if a type of protein that promotes cell division is produced in too great a quantity,” explains Martin Kircher, head of the BIH Junior Research Group on Computational Genome Biology and lead author of the paper.
Yet cancer cells are precisely where many mutations often occur – and some of these mutations have no impact while others actually cause or speed up the disease by influencing how much protein is produced. Before physicians prescribe a therapy that specifically combats certain mutations, they should know what role these play for the disease.

To help with this, a team of scientists around Dr Kircher took the control regions of 20 disease-relevant genes and modified them piece by piece – or to be more precise, the DNA base by base. For this purpose they developed a method that was able to perform these modifications in a high-throughput manner and allowed them to test them simultaneously. Using cell cultures, they examined what impact each modification had on protein production. “Some 85 percent of modifications have no measurable effect, while two-thirds of the remaining 15 percent reduce the amount of protein produced,” reports Dr Kircher. And the extent to which they effect cell activity is heavily dependent on the individual mutation and the control region investigated: “Replacing a base with another one usually has less impact than completely removing the base.”

The control elements investigated were from genes that are modified in patients suffering from cancer, heart failure, genetically high cholesterol, or various rare diseases. The researchers have made the results of their mutation analyses – more than 30,000 in total – freely available to anyone on the internet. Martin Kircher now hopes that this treasure trove of data will be used: “It would be great if physicians who have analyzed their patients’ DNA would consult our database to find out what effect the identified mutation, in all likelihood, has. This will enable them to assess whether the modification found in patients is suitable for a targeted therapy.”

The considerable time and effort needed to test 20 of possibly hundreds of thousands of control regions raises the question of whether machine learning or artificial intelligence could help predict which mutations produce which effects. There are already various computer programs that are trying to do exactly that. Dr Kircher and his colleagues therefore also studied how well different programs could predict the modifications observed in the cell culture. “The results were unfortunately very disappointing,” reports the Bioinformatician, “because the predictions rarely corresponded with our observations. Sometimes they even predicted the exact opposite.” The scientists now hope that their comprehensive data set can also be used to improve such predictive software.

Facts, background information, dossiers

  • mutations
  • cancer
  • mutation analysis

More about Berliner Institut für Gesundheitsforschung (BIh)

  • News

    The dangerous dual role of the immune system in COVID-19

    Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course: some of those infected do not even notice it, while others become so seriously ill that their lives are placed at risk. Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Be ... more

    Fine-tuning gene scissors

    The CRISPR-Cas9 gene-editing tool makes it possible to modify the genetic material of organisms. But CRISPR technology is not perfect. Frequently, these molecular “scissors” also make incisions in genetic regions that have a similar appearance to the target sequence. Researchers at the Berl ... more

More about Charité

  • News

    How the immune system paves the way for SARS-CoV-2

    The immune system actually wants to fight SARS-CoV-2 with antiviral signaling molecules. But a research team from Charité and MDC has now shown how such a signaling molecule can promote the replication of the virus. Most people infected with SARS-CoV-2 are able to recover from the disease a ... more

    How SARS-CoV-2 reaches the brain

    Using post-mortem tissue samples, a team of researchers from Charité – Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does. The results, which show ... more

    Highly effective antibodies against the coronavirus were identified

    Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: